XtalPi, Which Uses AI For Drug Discovery And Development, Raises $400M Series D Led By OrbiMed And RRJ, At A Valuation Of Over $2B

ai 400m orbimed 2b

XtalPi, a company that utilises AI to aid in the development and discovery of medicines, has raised $400 million in Series D, led by OrbiMed and RRJ, with a market value of more than $2 billionThe company offers its AI technology to pharmaceutical companies to boost their R&D and develop new drugs. AI-powered pharmaceutical company XtalPi has secured US$400 million…

XtalPi, which makes use of AI to aid in the development and discovery of medicines, has raised Series D 0M, which is led by OrbiMed and RRJ and RRJ, with a price of more than B (KrASIA). Source: Tech Meme

ai 400m orbimed rrj 2b

Recommended For You

uzair

About the Author: uzair

Uzair is a features writer at Cafeer.de. He is a graduate of Emerson College and recently completed the MFA in writing.

Leave a Reply

Your email address will not be published. Required fields are marked *